Pfizer and GlaxoSmithKline plan to combine their consumer healthcare units in a venture to create the world's largest over-the-counter drug business, The Wall Street Journal reports.
Pharmacy
Firdapse, an old, formerly inexpensive drug that treats a rare autoimmune disorder, just received a new $375,000 price tag, according to a STAT news report.
Hospital performance can be a moving target for hospital administrators due to changing regulatory pressures, reimbursement challenges and the transition from inpatient to ambulatory care.
Novartis CAR-T chief David Lebwohl is leaving the Swiss company to join Semma Therapeutics, a Cambridge, Mass.-based drugmaker developing a stem-cell cure for diabetes, according to EndPoints News.
Swiss drugmaker Novartis is looking to partner with global reinsurance companies to help health systems bear the cost of new generation, personalized therapies, according to the Financial Times.
Advertisement
Johnson & Johnson plans to repurchase up to $5 billion of its stock after losing more $50 billion in market value in two days of trading after a Reuters report surfaced that the drugmaker knew its baby powder contained carcinogenic…
Grocery chain Kroger has launched discount program for patients picking up prescription drugs at its pharmacies, according to a STAT news report.
As pressure mounts to reduce patient length of stay, skilled nursing facilities are particularly feeling the pinch of escalating drug costs, according to Skilled Nursing News.
Pharmacy benefit managers' business model is being threatened by federal regulatory and political efforts to cut healthcare costs; however, vertical mergers and acquisitions between PBMs and health insurers could deter some of these changes, according to Fitch Ratings.
Federal lawmakers have proposed legislation allowing HHS to push back on drug price hikes, according to a Reuters report.